首页> 外文会议>World biomaterials congress >Quantification of osteoclastic resorption of 3D biomaterials: towards better in vitro models for biomaterial degradation in vivo
【24h】

Quantification of osteoclastic resorption of 3D biomaterials: towards better in vitro models for biomaterial degradation in vivo

机译:量化3D生物材料的破骨细胞吸收:建立更好的体外生物材料体内降解模型

获取原文

摘要

Introduction: Resorbable bone graft materials have become an important alternative for autologous bone tissue for the regeneration of bone defects. The balance between new bone formation and resorption of the materials is crucial for successful remodeling. Cell-based resorption assays of biomaterials are performed using osteoclasts and osteoclast-like cell lines however the quantification of resorption pits requires planar substrates with relatively smooth surfaces (roughness below 1 μm). Therefore quantification of resorption activity through biochemical markers is desirable to evaluate the osteoclast-mediated degradation of 3D biomaterials. The focus of the present study was to explore possible correlations between the activity of osteoclast-specific enzymes tartrate-resistant acid phosphatase (TRAP), carbonic anhydrase Ⅱ (CAⅡ) and cathepsin K (CSK) and osteoclast formation and activity on different 2D and 3D biomaterials. Materials and Methods: Human peripheral blood mononuclear cells (PBMC) were isolated from buffy coats of more than 10 donors and were cultivated under stimulation with M-CSF and RANKL on cell culture polystyrene, membranes of mineralized collagen, calcium phosphate bone cements, collagen gels, bone chips and dentin. Osteoclast formation was studied microscopically (confocal laser scanning microscopy) and resorption pits, if appropriate, were analyzed using SEM. Comprehensive data sets were obtained for the activity of osteoclast-specific enzymes TRAP, CAⅡ and CSK at different time points of cultivation on the different materials. Results: The formation of multinucleated osteodasts was observed on all examined materials. However, number and size of osteodasts differed considerably on the materials, and there were also substantial differences between cells of different donors. TRAP activity did not always correlate with the osteoclast number and resorption area since also non-multinudeated cell species can be TRAP positive. Enzyme activity of CAⅡ and CSK showed a better correlation to osteoclast number and resorption area. Discussion: The quantification of osteodastic enzyme activities is commonly restricted to measurement of TRAP activity, while other osteodastic markers are only detected on gene expression level. This is the first study involving quantitative measurement of three different osteodastic enzyme activities of osteodasts on biomaterials. Our results indicate that measurement of TRAP activity is not sufficient to assess resorptive activity of osteodasts. CA Ⅱ activity gives better correlation to osteoclast formation than TRAP activity, however this assay might be disturbed by non-spedfic enzyme activities. CSK activity turned out to be a reliable marker for biomaterial resorption. More investigations involving other 3D biomaterial spedes like granules and foams are needed to consistently correlate CSK activity to osteodastic resorption. Conclusion: Quantitative measurement of osteoclast-specific enzyme activities, especially CAⅡ and CSK is an alternative method to assess osteodastic resorption of biomaterials. Enzyme activity quantification is advantageous in comparison to microscopic analyses since it is less time-consuming and also irregularly shaped materials can be examined.
机译:简介:可吸收的骨移植材料已成为自体骨组织再生骨缺损的重要替代方法。新骨形成与材料吸收之间的平衡对于成功重塑至关重要。使用破骨细胞和破骨细胞样细胞系进行生物材料的基于细胞的再吸收测定,但是对吸收凹坑的定量需要具有相对光滑表面(粗糙度低于1μm)的平面基质。因此,需要通过生化标记物对吸收活性进行定量,以评估破骨细胞介导的3D生物材料降解。本研究的重点是探讨破骨细胞特异性酶酒石酸盐抗性酸性磷酸酶(TRAP),碳酸酐酶Ⅱ(CAⅡ)和组织蛋白酶K(CSK)的活性与破骨细胞形成和不同2D和3D活性之间的可能相关性生物材料。材料与方法:从10多个供体的血沉棕黄层中分离出人外周血单核细胞(PBMC),并在M-CSF和RANKL刺激下在细胞培养聚苯乙烯,矿化胶原蛋白膜,磷酸钙骨水泥,胶原蛋白凝胶上培养,骨屑和牙本质。用显微镜研究(破骨激光扫描显微镜)破骨细胞的形成,并在适当的情况下使用SEM分析吸收凹坑。获得了关于破骨细胞特异性酶TRAP,CAⅡ和CSK在不同材料上不同培养时间点的活性的综合数据集。结果:在所有检查的材料上均观察到多核骨屑的形成。但是,在材料上,骨size的数量和大小差异很大,并且不同供体的细胞之间也存在实质性差异。 TRAP活性并不总是与破骨细胞数量和吸收面积相关,因为非多细胞细胞种类也可以是TRAP阳性。 CAⅡ和CSK的酶活性与破骨细胞数量和吸收面积具有较好的相关性。讨论:定量骨胶原酶的活性通常仅限于TRAP活性的测量,而其他骨胶原标记只能在基因表达水平上检测到。这是第一项涉及对生物材料上的骨d的三种不同的骨单位酶活性进行定量测量的研究。我们的结果表明,TRAP活性的测量不足以评估骨d的吸收活性。 CAⅡ活性与破骨细胞形成的相关性比TRAP活性好,但是该方法可能会受到非斯佩德奇酶活性的干扰。事实证明,CSK活性是生物材料吸收的可靠标志。为了使CSK活性始终与骨吸收相一致,还需要进行更多涉及其他3D生物材料加速剂的研究,例如颗粒和泡沫。结论:定量测定破骨细胞特异性酶的活性,尤其是CAⅡ和CSK是评估生物材料对骨吸收的一种替代方法。与显微分析相比,酶活性定量是有利的,因为它耗时少并且还可以检查形状不规则的材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号